Please login to the form below

Not currently logged in
Email:
Password:

MHRA launches medicines side effects awareness drive

Creates social media campaign as part of EU-wide initiative
MHRA SCOPE social media campaign still

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has launched a social media campaign on the importance of reporting suspected side effects.

As part of the EU-wide Strengthening Collaboration for Operating Pharmacovigilance in Europe (SCOPE) project, from 7-11 November the regulator aims to raise awareness of adverse drug reactions and improve the public's understanding of how to report them.

Most reporting systems suffer from underreporting and the agency hopes the SCOPE initiative will strengthen its system's cache as a result.

Mick Foy, group manager for MHRA's vigilance and risk management for its medicines division, said: “The most important part of our work is making sure the medicines you and your family take are effective and acceptably safe.

“Our campaign will help the public, patients and healthcare professionals report potential side effects and have confidence that their reports are making a difference.”

The campaign centres on an animation of a patient who has a suspected adverse reaction to a treatment. As the story unfolds, it shows how patients and healthcare professionals make reports to the MHRA and their benefit to future patients.

The MHRA credits such reports for action including no longer prescribing aspirin to children, which resulted in the virtual elimination of Reye's syndrome cases in many EU countries.

Foy added: “You can help make medicines safer by reporting any suspected side effects easily and quickly through our Yellow Card Scheme online or via the mobile app.”

Article by
Rebecca Clifford

4th November 2016

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...
Oh no… not more training
Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...

Infographics